Pra Health Sciences Inc (PRAH) Return on Investment ROI from the first quarter of 2021 to first quarter of 2020 and for the year 2021, average high and low, overall ranking from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Pra Health Sciences Inc's ROI from its first quarter of 2021 to the first quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pra Health Sciences Inc's ROI in the first quarter of 2021?
Pra Health Sciences Inc achieved a return on average invested assets (ROI) of 7.48 % in its first quarter of 2021, this is above PRAH's average return on investment of 5.86%.
Pra Health Sciences Inc s investments during the 12 months ending in the first quarter of 2021 are valued at $2 billion

ROI has improved compared to 7.1% in the fourth quarter of 2020, due to net income growth.

Within the Healthcare sector 139 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2020 from 737 to 1305.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Investment Change TTM 13.75 % 14.51 % 13.26 % 10.65 % 7.34 %
Y / Y Net Income Change TTM -10.94 % -18.95 % 31.05 % 148.9 % 441.22 %
Investment (TTM) in Millions 2,960 2,912 2,839 2,692 2,655
Return On Investment (TTM) 7.48 % 7.1 % 8.24 % 8.22 % 9.56 %
PRAH's Overall Ranking # 1305 # 737 # 517 # 0 # 428
Seq. Investment Change TTM 2.75 % 3.6 % 3.69 % 3.06 % 3.44 %
Seq. Net Income Change TTM 8.26 % -10.67 % 3.88 % -11.35 % -1.48 %
Net Income (TTM) in Millions 213 197 221 212 240

PRAH Company Profile >> Back to PRAH Roi Comparisons >> See Annual PRAH Return On Investment



Return On Investment PRAH's Ranking
Within: No.
Industry # 11
Sector # 140
Overall # 1305

Return On Investment Statistics
High Average Low
9.6 %
5.86 %
1.73 %
(Sep 30 2019)  







Financial Statements
Pra Health Sciences Inc's I. Quarter Investments $ 2,960 Millions PRAH's Balance sheet
Pra Health Sciences Inc's I. Quarter Income $ 57 Millions Quarterly PRAH's Income Statement
PRAH's Income by Division See PRAH's Income by Division


PRAH Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 2,912 2,527 2,294 2,392 1,626
Y / Y Investment Growth 15.24 % 10.17 % -4.1 % 47.1 % -4.27 %
Net Income in Millions 197 243 154 88 68
Y / Y Net Income Growth -18.95 % 57.4 % 76.2 % 28.58 % -16.62 %
Annual Return On Investment 6.77 % 9.62 % 6.73 % 3.66 % 4.19 %


Annual Roi Comment
In the fiscal year 2020 ROI decreased relative to the previous year to 6.77 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRAH's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRAH's Competitors
Subscribers only: Roi for Pra Health Sciences Inc's Suppliers
Subscribers only: Return On Investment for PRAH's Customers

Other Ratios
PRAH's Roa PRAH's Inventory Turnover Ratio PRAH's Growth Rates PRAH's Dividend Statistics
PRAH's Profitability Ratios PRAH's Asset Turnover Ratio PRAH's Dividend Growth
PRAH's Roe PRAH's Valuation Ratios PRAH's Financial Strength Ratios PRAH's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2021, within Healthcare Sector ROI
Organogenesis Holdings Inc   20.49 %
Corcept Therapeutics Inc  20.06 %
West Pharmaceutical Services Inc   19.45 %
Eli Lilly And Company  18.47 %
Abiomed Inc   17.92 %
Waters Corporation  17.90 %
Amedisys Inc  17.68 %
Revvity Inc  17.42 %
Voyager Therapeutics Inc   17.39 %
Moderna Inc   17.38 %
Incyte Corporation  16.87 %
Rayont Inc   16.79 %
Healthcare Services Group Inc   16.70 %
Atrion Corporation  16.13 %
Magellan Health inc   16.11 %
Masimo Corp  15.81 %
Emergent Biosolutions Inc   15.76 %
Biomarin Pharmaceutical Inc  15.50 %
Dexcom Inc   15.43 %
Zoetis Inc   15.26 %
Labcorp Holdings Inc   15.25 %
Quest Diagnostics Inc  15.20 %
Medpace Holdings Inc   15.10 %
Pacira Biosciences inc   15.06 %
3m Company  14.71 %
Biodelivery Sciences International Inc   14.59 %
Edwards Lifesciences Corporation  14.37 %
Biogen Inc   14.24 %
Nature s Sunshine Products inc   13.95 %
Encision Inc   13.80 %

Date modified: 2026-09-12T06:15:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.